3 Hot Stocks To Trade Right Now

Edward Lance lorilla,   "Coronavirus names" have been at the forefront of Kyle Dennis' Fast 5 trading watchlist over the recent weeks.   The virus is back to making headlines in many parts of the world and the tone isn't exactly a positive one.   The second wave, feared by many, might be turning into a reality.   New research coming out of Houston suggests that a mutation of the virus has arisen, possibly more infectious.   While that's nothing to cheer from a human standpoint, as traders— we have to take note.   This is why Kyle has a close eye on catalyst opportunities based on vaccine trial data and a possible prolongment of the stay-at-home economy.     Like the trade he recently put on in coronavirus stock, SRNE, in his Fast 5 trading service.   The company had some news about a license with the Mayo Clinic, so shares were getting some attention.   Kyle let his subscribers know about his gains shortly after alerting his entry. Here's 3 COVID names that Kyle has on his radar, ahead of his next Fast 5 alert he drops on Monday:   Moderna - MRNA   The company has one of the leading COVID vaccine candidates with crucial Phase 3 efficacy data due in November 2020.   As you're well aware, we're big fans of relative strength— MRNA has held reasonably well through both the COVID selloff and recent market meltdown.   With a second wave seemingly at our doorsteps, the company's vaccine candidate is as relevant as ever!   Buy Zone: $60-65   Profit Zone: $80+, likely to start taking profits in the $70s   Stop Zone: $58 or below   WARNING: Be wary of holding the stock overnight in November - data readout will either make it or break it. Novavax - NVAX   Novavax is another vaccine contender, albeit at a slightly earlier stage— they're just getting started with the Phase 2 trial.   Nonetheless, investors of all sizes obviously have faith in the stock— through the recent turbulence, it's performed far better than most of its peers.   If COVID names get a bid, we expect NVAX to be one of the prime beneficiaries.   Buy Zone: $90-105   Profit Zone: 135-145, taking some profits above 120   Stop Zone: $85 Teladoc Health - TDOC   Last, but not least, a not-so-obvious yet very much a COVID play— TDOC.   The company is in the business of telemedicine and has benefited greatly from the stay-at-home environment.   Its revenues for the year 2020 are expected to nearly double to $988M from $553M a year earlier.   It's business model was well-established even pre-corona.   And with seemingly no end to current restrictions in sight, this stock might have a lot more in store.   Buy Zone: $190-205   Profit Zone: $250-300; sell out of some above 240   Stop Zone: $180 or below Want to learn how Kyle is potentially trading one of these names?   Kyle releases his next highest-conviction Fast 5 alert on Monday.   For a limited time, Kyle is offering access to his Fast 5 trading service for just $17.   Take advantage of this limited-time $17 offer to learn more.     Revealed: Making Money Over The "Weekend" By Jason Bond of Jason Bond Picks Shining Light On The Dark Pools By Ben Sturgill of Daily Profit Machine SPI Energy's EV Subsidiary: Smoke and Mirrors? By Jeff Williams of Penny Pro Why I'm Bullish On The Market By Jason Bond of Weekly Windfalls How to Lose A Bunch of Money Without Trying By Jeff Bishop of RagingBull Investor RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 Click Here to stop receiving emails from support@ragingbull.com Unsubscribe from all RagingBull emails DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website,application or other service ("Services"), please review our full disclaimer located at https://ragingbull.com/disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication.